A recent study suggests that a drug approved for the treatment of seizures may also help treat Alzheimer's in people who do ...
A new study finds that it's not just about how much HDL a woman has — it's about the quality of those tiny, fat-carrying ...
Seltorexant is one of J&J’s most promising neuroscience candidates. The human orexin-2 receptor selective agonist produced ...
On Oct. 19 Sacred Heart University will hold a 'Walk to End Alzheimer's' on the university campus in Fairfield, one of ...
Cognito Therapeutics today announced a publication demonstrating structural brain preservation with its Spectris treatment.
Researchers used single-cell and spatial genomics to map cell-type-specific changes in the middle temporal gyrus, identifying ...
The neurodegenerative disorder affects millions of Americans, and its impact varies significantly across the country.
Alzheimer's disease is the most common cause of dementia. Here the Alzheimer's Society explains what Alzheimer's disease is.
Each year, about 2.5 million people suffer from traumatic brain injuries (TBI), which often increases their risk of ...